Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Health

Recently released market study: EpiCast Report: Bladder Cancer - Epidemiology Forecast to 2022


Print article Print article
2013-12-11 09:40:33 - Recently published research from GlobalData, "EpiCast Report: Bladder Cancer - Epidemiology Forecast to 2022", is now available at Fast Market Research

With more than 12 million new cases occurring worldwide each year, bladder cancer is estimated to be the ninth most common cancer, and the thirteenth most numerous cause of death from cancer (Parkin, 2008; Ploeg et al., 2009). The major risk factors for bladder cancer are exposure to smoking and occupational risk factors such as exposure to aromatic amines. These risk factors are more prevalent among men, which makes the disease the seventh most common cancer in men, whereas it is the seventeenth most common cancer in women (Ploeg et al., 2009). The majority of bladder cancer cases are among older individuals with the median age at diagnosis being 73 years; because of this, the comorbidities associated with bladder cancer

are similar to conditions typically occurring in older age and therefore, are not specific to bladder cancer (Prout et al., 2005).

By 2022, GlobalData epidemiologists forecast that the 6MM are expected to have 199,691 incident cases of bladder cancer, representing a 22.2% increase from the number of incident cases in 2012 (163,380 incident cases). In 2012, the 6MM had 575,251 five-year prevalent cases of bladder cancer and GlobalData epidemiologists forecast that by 2022, this number will grow to 703,227 five-year prevalent cases at an Annual Growth Rate (AGR) of 2.22%.
This forecast is supported by at least 10 years of historical data obtained from country-specific studies published by the World Health Organization's (WHO) International Agency for Research on Cancer (IARC), the National Cancer Institute's (NCI) Surveillance, Epidemiology, and End Results (SEER) Program, and the European Cancer Registry's fourth database registry (EUROCARE-4). The IARC's Cancer Incidence in Five Continents (CI-5) Plus data are the gold standard for country-level comparative analysis and was used to provide detailed case segmentation for each country by age and sex. Another major strength of this analysis is that GlobalData epidemiologists were able to forecast incident cases of bladder cancer in the 6MM by age, sex, and stage at diagnosis. Furthermore, the forecast methodology was also consistent across all markets, thereby allowing for a meaningful global comparison.

Full Report Details at
- www.fastmr.com/prod/752889_epicast_report_bladder_cancer_epidemi ..

Scope

* The Bladder Cancer EpiCast Report provides an overview of the risk factors and global trends of bladder cancer in the 6MM (US, France, Germany, Italy, Spain, and UK). It includes a 10-year epidemiological forecast for the incident cases of bladder cancer segmented by sex, age (in five-year age groups beginning at 15 years and ending at 75 years and older), and cancer stage at diagnosis (in situ, local, regional, distant, and unstaged), in addition to five-year prevalent cases in these markets.
* The bladder cancer epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
* The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.

Reasons to Get this Report

* Develop business strategies by understanding the trends shaping and driving the global bladder cancer market.
* Quantify patient populations in the global bladder cancer market to improve product design, pricing, and launch plans.
* Organize sales and marketing efforts by identifying the sex and age groups that present the best opportunities for bladder cancer therapeutics in each of the markets covered.

Partial Table of Contents:

1 Table of Contents
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Catalyst
2.2 Upcoming Reports
3 Epidemiology
3.1 Disease Background
3.2 Risk Factors and Comorbidities
3.2.1 Smoking is the most significant risk factor for bladder cancer
3.2.2 Up to 25% of male bladder cancer cases are due to occupational exposure to aromatic amines
3.3 Global Trends
3.3.1 Incidence, Mortality, and Five-Year Prevalence
3.3.2 Relative Survival
3.3.3 Disability-Adjusted Life Years (DALYs) and Years of Life Lost (YLLs)
3.4 Forecast Methodology
3.4.1 Sources Used
3.4.2 Sources Not Used
3.4.3 Forecast Assumptions and Methods
3.5 Epidemiological Forecast for Bladder Cancer (2012-2022)
3.5.1 Incident Cases of Bladder Cancer
3.5.2 Age-Specific Incident Cases of Bladder Cancer
3.5.3 Sex-Specific Incident Cases of Bladder Cancer
3.5.4 Age-Standardized Incidence Rates of Bladder Cancer
3.5.5 Incident Cases of Bladder Cancer by Stage at Diagnosis
3.5.6 Five-Year Prevalent Cases of Bladder Cancer
3.6 Discussion
3.6.1 Epidemiological Forecast Insight
3.6.2 Limitations of the Analysis
3.6.3 Strengths of the Analysis
4 Appendix
4.1 Bibliography
4.2 About the Authors
4.2.1 Epidemiologists
4.2.2 Reviewers
4.2.3 Global Director of Epidemiology and Health Policy
4.2.4 Global Head of Healthcare
4.3 About GlobalData
4.4 About EpiCast
4.5 Disclaimer

List of Tables

1.1 List of Tables
Table 1: Bladder Cancer Risk Factors
Table 2: 6MM, GLOBOCAN Incidence, Five-Year Prevalence, and Mortality of Bladder Cancer, Ages ≥15 Years, Men and Women, 2008
Table 3: 6MM, Relative Survival of Bladder Cancer (%), Men and Women
Table 4: 6MM, GLOBOCAN Disability-Adjusted Life Years (DALYs) and Years of Life Lost (YLLs) Due to Bladder Cancer, Men and Women, N, 2008
Table 5: 6MM, Sources of Bladder Cancer Incidence Data
Table 6: 6MM, Incident Cases of Bladder Cancer, Ages ≥15 Years, Men and Women, N, Select Years 2012-2022
Table 7: 6MM, Age-Specific Incident Cases of Bladder Cancer, Ages ≥15 Years, Men and Women, N (Row %), 2012
Table 8: 6MM, Sex-Specific Incident Cases of Bladder Cancer, Ages ≥15 Years, Men and Women, N (Row %), 2012

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=752889&dt=t

About GlobalData

GlobalData is a leading provider of global business intelligence including market, competitor, product and customer information. It provides in-depth research, analysis, data and forecasts through a range of interactive online databases, reports and management briefings. GlobalData has a large team of experienced research and analysis, consulting, and marketing experts. It has a global presence, including key offices in the US, Europe and Asia. The group has over 50 years of experience of delivering market intelligence data and analysis and a highly experienced senior management team. View more research from GlobalData at www.fastmr.com/catalog/publishers.aspx?pubid=1015

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.


Author:
Bill Thompson
e-mail
Web: www.fastmr.com
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com